Related references
Note: Only part of the references are listed.Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism
V. A. DANIS et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
A. Ruzzo et al.
PHARMACOGENOMICS JOURNAL (2008)
High-resolution DNA melting analysis for simple and efficient molecular diagnostics
Gudrun H. Reed et al.
PHARMACOGENOMICS (2007)
Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels
S. Rafiq et al.
GENES AND IMMUNITY (2007)
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy
Annamaria Ruzzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
Anne M. Lewis et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Interleukin-1 system gene polymorphisms are associated with fat mass in young men
Louise Strandberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The role of interleukin 1 in growth and metastasis of human cancer cenografts
DM Elaraj et al.
CLINICAL CANCER RESEARCH (2006)
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
Ron N. Apte et al.
CANCER AND METASTASIS REVIEWS (2006)
Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line
A Grothey et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic role of interleukin-1β gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer
F Graziano et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci
YY Shi et al.
CELL RESEARCH (2005)
Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma
N Konishi et al.
ONCOLOGY (2005)
Regulation of vascular endothelial growth factor expression in human gastric cancer cells by interleukin-1β
M Kawaguchi et al.
SURGERY (2004)
Haplotype reconstruction from genotype data using Imperfect Phylogeny
E Halperin et al.
BIOINFORMATICS (2004)
Cytokines in pancreatic carcinoma - Correlation with phenotypic characteristics and prognosis
B Ebrahimi et al.
CANCER (2004)
Interleukin (IL)-1 gene polymorphisms:: relevance of disease severity associated alleles with IL-1β and IL-1ra production in multiple sclerosis
HM Schrijver et al.
MEDIATORS OF INFLAMMATION (2003)
IL-1 is required for tumor invasiveness and angiogenesis
E Voronov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies
A Laviano et al.
LANCET ONCOLOGY (2003)
Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1β after live yellow fever vaccination
UT Hacker et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Share Paper
